Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Bupivacaine hydrochloride; epinephrine bitartrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bupivacaine hydrochloride; epinephrine bitartrate and what is the scope of bupivacaine hydrochloride; epinephrine bitartrate patent protection?

Bupivacaine hydrochloride; epinephrine bitartrate
is the generic ingredient in five branded drugs marketed by Fresenius Kabi Usa, Hospira, and Septodont, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for bupivacaine hydrochloride; epinephrine bitartrate. Fourteen suppliers are listed for this compound.

Summary for Generic Name: bupivacaine hydrochloride; epinephrine bitartrate

Tradenames:5
Patents:1
Applicants:3
NDAs:7
Drug Master File Entries: see list10
Suppliers / Packagers: see list14
Clinical Trials: see list1,431
Drug Prices:see low prices
DailyMed Link:bupivacaine hydrochloride; epinephrine bitartrate at DailyMed

Pharmacology for Ingredient: bupivacaine hydrochloride; epinephrine bitartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION022046-001Jul 13, 1983APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION016964-010Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION016964-013Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Fresenius Kabi Usa
SENSORCAINE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION070968-001Oct 13, 1987APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
SENSORCAINE
bupivacaine hydrochloride; epinephrine bitartrate
INJECTABLE;INJECTION018304-005Sep 2, 1983APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot